← FDA Drug Approvals (Drugs@FDA)

ETODOLAC

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IPCA LABS LTD · Approved 2024-05-01

Drug application

FDA Application #

ANDA204729

Application type

Abbreviated New Drug Application (Generic)

Brand name

ETODOLAC

Generic name

ETODOLAC

Active ingredients

ETODOLAC

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

IPCA LABS LTD

Manufacturer

Ipca Laboratories Limited

First approval

2024-05-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown